Table 3.
Effect of NPs coating on tissue biodistribution.
| Authors | Nanoparticle | Coating added | Distribution |
|---|---|---|---|
| Zhang et al. [60] | Gold NPs | Zwitterionic polycarboxybetaine (PCB) | PK behavior was unchanged, no antiuricase detected, no anti-PCB antibodies detected |
| Rodriguez et al. [62] | 160 nm nanobeads | CD47 “self” peptides | Prolonged drug circulation by delaying phagocytic clearance by the liver and spleen |
| Kreuter et al. [63] | poly(butyl cyanoacrylate) nanoparticles | Polysorbate 80 | enhanced drug delivery beyond the blood-brain barrier |
| Parodi et al. [64] | Nanoporous silicon particles (NPS) | Membranes purified from white blood | Prolonged circulation time |
| Hu et al. [65] | Polymeric nanoparticles | Erythrocyte membrane | Prolonged circulation time |
| Romberg et al. [55] | Liposome | Poly(hydroxyethyl-L-asparagine) (PHEA) | Longer blood circulation times than PEG liposomes. The second injection less rapidly cleared from the circulation than the second dose of PEG liposomes |
| Lila et al. [66] | Liposome | Polyglycerol (PG) | Reduced effect of ABC when using polyglycerol compared to PEG |